A UT Southwestern Medical Center quality improvement team led a large-scale, multispecialty project in partnership with the ...

ABANZA, a leader in advanced soft tissue repair solutions, is proud to announce that the U.S. Food and Drug Administration ...

Staar’s job cuts come “amid ongoing macroeconomic and geopolitical challenges that have pressured the business,” a ...

Implantable cardiac devices play a significant role in decreasing the morbidity and mortality in patients with cardiovascular disease. Tissue-device interactions leading to systemic ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

Implantable sensors can provide access to accurate, continuous, and minimally invasive monitoring of physiological signals from internal organs and tissues, thereby facilitating timely diagnosis ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...